Breitung Knut, Remmerbach Torsten W
Gemeinschaftspraxis Hradschin 14 Dres. Altekrüger, Heinert, Preussner und Winkler, Hradschin 14, D-08523 Plauen.
Schweiz Monatsschr Zahnmed. 2010;120(6):525-31.
Medically induced gingival overgrowth is one of the major side effects of phenytoine, cyclosporine A and the channel blocker Nifedipine and it is well documented in various studies and case series. Recently an alternative channel blocker, Amlodipine, has been implemented into the clinical treatment of cardiovascular diseases. By means of a clinical case presentation it was shown that Amlodipine is able to induce gingival overgrowth in the oral cavity as well. Additionally, the causes of Amlodipine-induced gingival hyperplasia are critically discussed and several options of therapy modalities presented.
药物性牙龈增生是苯妥英钠、环孢素A和钙通道阻滞剂硝苯地平的主要副作用之一,在各种研究和病例系列中有充分记载。最近,一种新型钙通道阻滞剂氨氯地平已应用于心血管疾病的临床治疗。通过一个临床病例展示表明,氨氯地平也能够在口腔中引起牙龈增生。此外,对氨氯地平所致牙龈增生的病因进行了批判性讨论,并提出了几种治疗方式的选择。